We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 4.675 | 4.36 | 4.99 | - | 60,335 | 08:00:27 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.41M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 30/9/2020 22:17 | From lse board... Sng001 available in France via ATU Get in there! | oranolio | |
| 30/9/2020 21:56 | monkeywench, I think that was the original Synairgen sponsored trial. John Bell (who I think is in charge of the recovery trial) mentions it at around 59.30 here | davemac3 | |
| 30/9/2020 21:55 | List of all Recovery trials for those interested. hxxps://www.nihr.ac. | monkeywench1 | |
| 30/9/2020 21:51 | Old news. hxxps://www.nihr.ac. hxxps://www.covidtri | monkeywench1 | |
| 30/9/2020 21:47 | DaveMac how do you know that? | sloppyjoe2 | |
| 30/9/2020 21:34 | The Oxford RECOVERY trial funded by the UK government is looking at inhaled B-interferon (presumably SNG001) as a treatment for Covid-19. | davemac3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
